The Nature and Influence of Pharmaceutical Industry Involvement in Asthma Trials | Zendy

Kenneth Bond | Zendy; Carol Spooner | Zendy; Lisa Tjosvold | Zendy; Catherine Lemière | Zendy; Brian H. Rowe | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Nature and Influence of Pharmaceutical Industry Involvement in Asthma Trials

Author(s) -

Kenneth Bond,

Carol Spooner,

Lisa Tjosvold,

Catherine Lemière,

Brian H. Rowe

Publication year - 2012

Publication title -

canadian respiratory journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.675

H-Index - 53

eISSN - 1916-7245

pISSN - 1198-2241

DOI - 10.1155/2012/890457

Subject(s) - medicine , interquartile range , pharmaceutical industry , asthma , clinical trial , family medicine , pharmacology

Pharmaceutical industry-sponsored research has been shown to be biased toward reporting positive results. Frequent industry participation in trials assessing the efficacy of inhaled corticosteroid (ICS) and long-acting beta<span style="vertical-align: sub">2<⁄span>-agonist (LABA) combination treatment makes assessing industry influence difficult and warrants an assessment of specific potential publication bias in this area.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research